Sight Sciences, Inc. (SGHT) Insider Trading

Last 12 months

Insiders bought $185k and sold $2.87M on the open market.

76% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−$2.68M

2 buys · 32 sales

Under a 10b5-1 plan

76%

of the value sold

Insiders who bought / sold

1 / 6

executives and directors

Last open-market buy

Jun 2026

Jun 10, 2026

Get an email when SGHT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 2	Brenton Taylor EVP, Operations & R&D	Sold10b5-1 plan	2,988	$8.85	$26k	1.1%	Form 4
Oct 2	Alison Bauerlein Chief Operating Officer	Sold10b5-1 plan	25,260	$8.85	$224k	3.8%	Form 4
Oct 2	James Rodberg Chief Financial Officer	Sold10b5-1 plan	7,208	$8.85	$64k	3.2%	Form 4
Oct 1	David Badawi Chief Technology Officer	Sold10b5-1 plan	7,797	$9.05	$71k	0.4%	Form 4
Oct 1	Paul Badawi President and CEO	Sold10b5-1 plan	29,653	$9.05	$268k	0.5%	Form 4
Jul 6	Jeremy B. Hayden Chief Legal Officer	Sold10b5-1 plan	12,733	$5.51	$70k	3.4%	Form 4
Jul 6	David Badawi Chief Technology Officer	Sold10b5-1 plan	7,418	$5.51	$41k	0.4%	Form 4
Jul 2	James Rodberg Chief Financial Officer	Sold10b5-1 plan	6,902	$5.36	$37k	3.0%	Form 4
Jul 2	Alison Bauerlein Chief Operating Officer	Sold10b5-1 plan	24,184	$5.36	$130k	3.5%	Form 4
Jul 1	Brenton Taylor EVP, Operations & R&D	Sold10b5-1 plan	2,829	$5.42	$15k	1.1%	Form 4
Jul 1	Paul Badawi President and CEO	Sold10b5-1 plan	28,684	$5.42	$155k	0.5%	Form 4
Jun 10	Staffan Encrantz Director	Bought	14,100	$4.88	$69k	0.7%	Form 4
May 18	Alison Bauerlein Chief Operating Officer	Sold10b5-1 plan	12,728	$5.12	$65k	1.8%	Form 4
Apr 6	James Rodberg Chief Financial Officer	Sold10b5-1 plan	7,231	$3.55	$26k	3.0%	Form 4
Apr 6	Jeremy B. Hayden Chief Legal Officer	Sold10b5-1 plan	13,761	$3.55	$49k	3.6%	Form 4
Apr 2	Alison Bauerlein Chief Operating Officer	Sold10b5-1 plan	25,874	$3.48	$90k	3.6%	Form 4
Apr 2	David Badawi Chief Technology Officer	Sold10b5-1 plan	8,168	$3.48	$28k	0.4%	Form 4
Apr 1	Brenton Taylor EVP, Operations & R&D	Sold10b5-1 plan	2,869	$3.70	$11k	1.1%	Form 4
Apr 1	Paul Badawi President and CEO	Sold10b5-1 plan	29,244	$3.70	$108k	0.5%	Form 4
Jan 16	David Badawi Chief Technology Officer	Sold10b5-1 plan	4,836	$6.62	$32k	0.3%	Form 4
Jan 16	James Rodberg Chief Financial Officer	Sold10b5-1 plan	2,616	$6.62	$17k	1.7%	Form 4
Jan 16	Paul Badawi President and CEO	Sold10b5-1 plan	22,362	$6.62	$148k	0.4%	Form 4
Jan 16	Jeremy B. Hayden Chief Legal Officer	Sold10b5-1 plan	6,308	$6.62	$42k	2.3%	Form 4
Jan 2 – 6	Paul Badawi President and CEO	SoldNo plan 2 parts	37,226	$7.45 average	$277k	0.6%	Form 4
Jan 5 – 6	Jeremy B. Hayden Chief Legal Officer	Sold10b5-1 plan 2 parts	11,170	$7.77 average	$87k	4.4%	Form 4
Jan 2 – 6	David Badawi Chief Technology Officer	SoldNo plan 3 parts	9,660	$7.57 average	$73k	0.5%	Form 4
Jan 5 – 6	James Rodberg Chief Financial Officer	SoldNo plan 2 parts	4,999	$7.78 average	$39k	3.1%	Form 4
Jan 5 – 6	Alison Bauerlein Chief Operating Officer	SoldNo plan 2 parts	20,543	$7.66 average	$157k	3.3%	Form 4
Jan 6	Brenton Taylor EVP, Operations & R&D	SoldNo plan	619	$7.48	$5k	0.4%	Form 4
Dec 16, 2025	Staffan Encrantz Director	Bought	13,958	$8.31	$116k	0.2%	Form 4
Dec 2, 2025	James Rodberg Chief Financial Officer	SoldNo plan	2,518	$8.25	$21k	1.6%	Form 4
Nov 25, 2025	Jeremy B. Hayden Chief Legal Officer	Sold10b5-1 plan	44,850	$8.08	$362k	15%	Form 4
Nov 17, 2025	Brenton Taylor EVP, Operations & R&D	SoldNo plan	14,418	$7.06	$102k	7.8%	Form 4
Nov 12, 2025	Jeremy B. Hayden Chief Legal Officer	Sold10b5-1 plan	3,150	$8.01	$25k	1.2%	Form 4
Oct 6, 2025	Brenton Taylor EVP, Operations & R&D	SoldNo plan	591	$3.37	$2k	0.3%	Form 4
Oct 3, 2025	David Badawi Chief Technology Officer	SoldNo plan	6,033	$3.27	$20k	0.3%	Form 4
Oct 3, 2025	Jeremy B. Hayden Chief Legal Officer	SoldNo plan	9,731	$3.27	$32k	3.7%	Form 4
Oct 2, 2025	Alison Bauerlein Chief Financial Officer	SoldNo plan	19,948	$3.30	$66k	3.2%	Form 4
Oct 1, 2025	Paul Badawi President and CEO	SoldNo plan	24,441	$3.34	$82k	0.4%	Form 4
Jul 3, 2025	Jeremy B. Hayden Chief Legal Officer	SoldNo plan	9,160	$4.17	$38k	3.3%	Form 4

Oct 210b5-1 plan
Brenton Taylor
EVP, Operations & R&D · sold 2,988 at $8.85
$26k
1.1% of stake
Oct 210b5-1 plan
Alison Bauerlein
Chief Operating Officer · sold 25,260 at $8.85
$224k
3.8% of stake
Oct 210b5-1 plan
James Rodberg
Chief Financial Officer · sold 7,208 at $8.85
$64k
3.2% of stake
Oct 110b5-1 plan
David Badawi
Chief Technology Officer · sold 7,797 at $9.05
$71k
0.4% of stake
Oct 110b5-1 plan
Paul Badawi
President and CEO · sold 29,653 at $9.05
$268k
0.5% of stake
Jul 610b5-1 plan
Jeremy B. Hayden
Chief Legal Officer · sold 12,733 at $5.51
$70k
3.4% of stake
Jul 610b5-1 plan
David Badawi
Chief Technology Officer · sold 7,418 at $5.51
$41k
0.4% of stake
Jul 210b5-1 plan
James Rodberg
Chief Financial Officer · sold 6,902 at $5.36
$37k
3.0% of stake
Jul 210b5-1 plan
Alison Bauerlein
Chief Operating Officer · sold 24,184 at $5.36
$130k
3.5% of stake
Jul 110b5-1 plan
Brenton Taylor
EVP, Operations & R&D · sold 2,829 at $5.42
$15k
1.1% of stake
Jul 110b5-1 plan
Paul Badawi
President and CEO · sold 28,684 at $5.42
$155k
0.5% of stake
Jun 10
Staffan Encrantz
Director · bought 14,100 at $4.88
$69k
0.7% of stake
May 1810b5-1 plan
Alison Bauerlein
Chief Operating Officer · sold 12,728 at $5.12
$65k
1.8% of stake
Apr 610b5-1 plan
James Rodberg
Chief Financial Officer · sold 7,231 at $3.55
$26k
3.0% of stake
Apr 610b5-1 plan
Jeremy B. Hayden
Chief Legal Officer · sold 13,761 at $3.55
$49k
3.6% of stake
Apr 210b5-1 plan
Alison Bauerlein
Chief Operating Officer · sold 25,874 at $3.48
$90k
3.6% of stake
Apr 210b5-1 plan
David Badawi
Chief Technology Officer · sold 8,168 at $3.48
$28k
0.4% of stake
Apr 110b5-1 plan
Brenton Taylor
EVP, Operations & R&D · sold 2,869 at $3.70
$11k
1.1% of stake
Apr 110b5-1 plan
Paul Badawi
President and CEO · sold 29,244 at $3.70
$108k
0.5% of stake
Jan 1610b5-1 plan
David Badawi
Chief Technology Officer · sold 4,836 at $6.62
$32k
0.3% of stake
Jan 1610b5-1 plan
James Rodberg
Chief Financial Officer · sold 2,616 at $6.62
$17k
1.7% of stake
Jan 1610b5-1 plan
Paul Badawi
President and CEO · sold 22,362 at $6.62
$148k
0.4% of stake
Jan 1610b5-1 plan
Jeremy B. Hayden
Chief Legal Officer · sold 6,308 at $6.62
$42k
2.3% of stake
Jan 2 – 6No plan
Paul Badawi
President and CEO · sold 37,226 at avg $7.45
$277k
0.6% of stake
Jan 5 – 610b5-1 plan
Jeremy B. Hayden
Chief Legal Officer · sold 11,170 at avg $7.77
$87k
4.4% of stake
Jan 2 – 6No plan
David Badawi
Chief Technology Officer · sold 9,660 at avg $7.57
$73k
0.5% of stake
Jan 5 – 6No plan
James Rodberg
Chief Financial Officer · sold 4,999 at avg $7.78
$39k
3.1% of stake
Jan 5 – 6No plan
Alison Bauerlein
Chief Operating Officer · sold 20,543 at avg $7.66
$157k
3.3% of stake
Jan 6No plan
Brenton Taylor
EVP, Operations & R&D · sold 619 at $7.48
$5k
0.4% of stake
Dec 16, 2025
Staffan Encrantz
Director · bought 13,958 at $8.31
$116k
0.2% of stake
Dec 2, 2025No plan
James Rodberg
Chief Financial Officer · sold 2,518 at $8.25
$21k
1.6% of stake
Nov 25, 202510b5-1 plan
Jeremy B. Hayden
Chief Legal Officer · sold 44,850 at $8.08
$362k
15% of stake
Nov 17, 2025No plan
Brenton Taylor
EVP, Operations & R&D · sold 14,418 at $7.06
$102k
7.8% of stake
Nov 12, 202510b5-1 plan
Jeremy B. Hayden
Chief Legal Officer · sold 3,150 at $8.01
$25k
1.2% of stake
Oct 6, 2025No plan
Brenton Taylor
EVP, Operations & R&D · sold 591 at $3.37
$2k
0.3% of stake
Oct 3, 2025No plan
David Badawi
Chief Technology Officer · sold 6,033 at $3.27
$20k
0.3% of stake
Oct 3, 2025No plan
Jeremy B. Hayden
Chief Legal Officer · sold 9,731 at $3.27
$32k
3.7% of stake
Oct 2, 2025No plan
Alison Bauerlein
Chief Financial Officer · sold 19,948 at $3.30
$66k
3.2% of stake
Oct 1, 2025No plan
Paul Badawi
President and CEO · sold 24,441 at $3.34
$82k
0.4% of stake
Jul 3, 2025No plan
Jeremy B. Hayden
Chief Legal Officer · sold 9,160 at $4.17
$38k
3.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SGHT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

IRMDIradimed Corp

TELATela Bio Inc.

LUNGPulmonx Corporation

PDEXPro-Dex Inc.

RCELAvita Medical Inc.

DCTHDelcath Systems Inc.

MHUAFMeihua International Medical Technologies Co., Ltd.

NPCENeuroPace Inc.

Spot a number that looks wrong? Check it in SGHT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SGHT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.